GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GC91703 structure
    GC91703AL 34662 (formate)
    Purity: >98.00%

    AL 34662 is an agonist of the serotonin (5-HT) receptor subtype 5-HT2.

  • GC91705 structure
    GC91705Etomidate-d5
    Purity: >99.00%

    Etomidate-d5 is intended for use as an internal standard for the quantification of etomidate by GC- or LC-MS.

  • GC91737 structure
    GC9173777PD-Q
    CAS: 3078541-61-1
    Purity: >98.00%

    77PD-Q est une quinone dérivée de la para-phénylènediamine; on le trouve surtout dans les particules en suspension dans l'air.

  • GC91761 structure
    GC91761ABBV-CLS-484 (hydrochloride)
    Purity: >98.00%

    ABBV-CLS-484 is a dual inhibitor of protein tyrosine phosphatase 1N (PTP1N) and PTP2N (IC50s = 2.5 and 1.8 nM, respectively).

  • GC91764 structure
    GC91764Ochratoxin B-13C20
    Purity: >98.00%

    Ochratoxin B-13C20 (OTB-13C20) is intended for use as an internal standard for the quantification of ochratoxin B by GC- or LC-MS.

  • GC91767 structure
    GC91767ENPP3 Inhibitor 5J
    Purity: >95.00%

    ENPP3 inhibitor 5J is an inhibitor of ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1) and ENPP3 (IC50s = 0.59 and 0.62 µM, respectively, for the human enzymes).

  • GC91768 structure
    GC91768GSK205 (hydrobromide)
    Purity: >95.00%

    GSK205 is an inhibitor of transient receptor potential vanilloid 4 (TRPV4) and transient receptor potential ankyrin 1 (TRPA1; IC50s = 4.19 and 5.56 µM, respectively, for the rat channels).

  • GC91773 structure
    GC9177318-hydroxy Oleoyl Leucine-d7
    Purity: >99.00%

    18-hydroxy Oleoyl leucine-d7 is intended for use as an internal standard for the quantification of 18-hydroxy oleoyl leucine by GC- or LC-MS.

  • GC91775 structure
    GC91775h-e5'NT Inhibitor 5C
    Purity: >95.00%

    h-e5'NT Inhibitor 5C is an inhibitor of ecto-5'-nucleotidase, also known as CD73 (IC50s = 0.37 and 1.66 µM for the human and rat enzymes, respectively).

  • GC91776 structure
    GC91776PD-1/PD-L1 Inhibitor N11
    Purity: >95.00%

    PD-1/PD-L1 inhibitor N11 is an inhibitor of the protein-protein interaction between programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1; IC50 = 6.3 nM).

  • GC91777 structure
    GC91777NVS-STG2
    Purity: >98.00%

    NVS-STG2 is an agonist of stimulator of interferon genes (STING).

  • GC91779 structure
    GC91779Ochratoxin C-13C20
    Purity: >98.00%

    Ochratoxin C-13C20 (OTC-13C20) is intended for use as an internal standard for the quantification of ochratoxin C by GC- or LC-MS.

  • GC91780 structure
    GC91780BODIPY-Linoleate
    Purity: >95.00%

    BODIPY-Linoleate is a fluorescently tagged derivative of linoleic acid .

  • GC91782 structure
    GC91782DPP-9 Inhibitor 42
    Purity: >95.00%

    DPP-9 inhibitor 42 is an inhibitor of dipeptidyl peptidase 9 (DDP-9; IC50 = 0.0034 µM).

  • GC91783 structure
    GC91783FA16
    Purity: >95.00%

    FA16 is a ferroptosis inducer and an inhibitor of the system xc- cystine/glutamate transporter.

  • GC91789 structure
    GC91789LB244
    Purity: >95.00%

    LB244 is an irreversible STING antagonist.

  • GC91790 structure
    GC91790AMG PERK 44 (hydrochloride)
    Purity: >98.00%

    AMG PERK 44 is a protein kinase R-like ER kinase (PERK) inhibitor (IC50 = 6 nM).

  • GC91791 structure
    GC91791Cholic Acid 3-sulfate (potassium salt)
    Purity: >98.00%

    Cholic acid 3-sulfate is a metabolite of the primary bile acid cholic acid .

  • GC91800 structure
    GC91800CPPA-TPP
    Purity: >75.00%

    CPPA-TPP is a chain transfer agent conjugated to the mitochondria-targeting moiety triphenylphosphonium (TPP).

  • GC91805 structure
    GC91805DB2313 (hydrochloride)
    Purity: >98.00%

    DB2313 is an inhibitor of the transcription factor PU.

  • GC91812 structure
    GC91812Cy5-Yne (triethylamine salt)
    Purity: >95.00%

    Cy5-Yne is a clickable azido-reactive fluorescent probe.

  • GC91815 structure
    GC91815BODIPY 480/508-Cholesteryl Oleate
    Purity: >95.00%

    BODIPY 480/508-cholesteryl oleate is a cell-permeable and fluorescently tagged derivative of cholesteryl oleate .

  • GC91820 structure
    GC91820PDIC-NS
    Purity: >95.00%

    PDIC-NS is an activator of stimulator of interferon genes (STING).

  • GC91829 structure
    GC91829Acriflavine Mixture
    Purity: >95.00%

    Acriflavine mixture is a mixture of proflavine, acriflavine, side-methylated proflavine, and side-methylated acriflavine.